-
H.
Shihab,
L.
Meoni,
Audrey
Chu,
Nae-Yuh
Wang,
D.
Ford,
K.
Liang,
J.
Gallo,
M.
Klag
(2012)
Body Mass Index and Risk of Incident Hypertension Over the Life Course: The Johns Hopkins Precursors Study
Circulation, 126
-
C.
Gillespie,
Kimberly
Hurvitz
(2013)
Prevalence of hypertension and controlled hypertension - United States, 2007-2010.
MMWR supplements, 62 3
-
P.
Österlund,
L.
Soveri,
H.
Isoniemi,
T.
Poussa,
T.
Alanko,
P.
Bono,
P.
Bono
(2011)
Hypertension and overall survival in metastatic colorectal cancer patients treated with bevacizumab-containing chemotherapy
British Journal of Cancer, 104
-
J.
Halimi,
B.
Giraudeau,
S.
Vol,
E.
Cacès,
H.
Nivet,
J.
Tichet
(2002)
The risk of hypertension in men: direct and indirect effects of chronic smoking
Journal of Hypertension, 20
-
Yumi
Koizumi,
Y.
Hamazaki,
M.
Okuro,
O.
Iritani,
Hiroshi
Yano,
Toshihiro
Higashikawa,
K.
Iwai,
S.
Morimoto
(2013)
Association between hypertension status and the screening test for frailty in elderly community-dwelling Japanese
Hypertension Research, 36
-
M.
Miyake,
Masaomi
Kuwada,
S.
Hori,
Y.
Morizawa,
Y.
Tatsumi,
S.
Anai,
Y.
Hosokawa,
Y.
Hayashi,
A.
Tomioka,
T.
Otani,
K.
Otsuka,
Y.
Nakagawa,
Y.
Nakai,
S.
Samma,
N.
Tanaka,
K.
Fujimoto
(2016)
The best objective response of target lesions and the incidence of treatment-related hypertension are associated with the survival of patients with metastatic renal cell carcinoma treated with sunitinib: a Japanese retrospective study
BMC Research Notes, 9
-
R.
Motzer,
Thomas
Hutson,
D.
Cella,
J.
Reeves,
R.
Hawkins,
Jun
Guo,
P.
Nathan,
M.
Staehler,
P.
Souza,
J.
Merchan,
E.
Boleti,
K.
Fife,
Jie
Jin,
Robert
Jones,
H.
Uemura,
U.
Giorgi,
U.
Harmenberg,
Jinwan
Wang,
C.
Sternberg,
K.
Deen,
L.
McCann,
M.
Hackshaw,
R.
Crescenzo,
L.
Pandite,
T.
Choueiri
(2013)
Pazopanib versus sunitinib in metastatic renal-cell carcinoma.
The New England journal of medicine, 369 8
-
A.
Nakaya,
T.
Kurata,
T.
Yokoi,
S.
Iwamoto,
Yoshitaro
Torii,
Y.
Katashiba,
Makoto
Ogata,
M.
Hamada,
M.
Kon,
S.
Nomura
(2016)
Retrospective analysis of bevacizumab‐induced hypertension and clinical outcome in patients with colorectal cancer and lung cancer
Cancer Medicine, 5
-
K.
Eechoute,
A.
Veldt,
S.
Oosting,
M.
Kappers,
J.
Wessels,
H.
Gelderblom,
H.
Guchelaar,
A.
Reyners,
C.
Herpen,
J.
Haanen,
J.
Haanen,
R.
Mathijssen,
E.
Boven
(2012)
Polymorphisms in Endothelial Nitric Oxide Synthase (eNOS) and Vascular Endothelial Growth Factor (VEGF) Predict Sunitinib‐Induced Hypertension
Clinical Pharmacology & Therapeutics, 92
-
R.
Wu,
Peter
Lindenberg,
R.
Slack,
A.
Noone,
J.
Marshall,
A.
He
(2009)
Evaluation of Hypertension as a Marker of Bevacizumab Efficacy
Journal of Gastrointestinal Cancer, 40
-
R.
Motzer,
N.
Haas,
F.
Donskov,
M.
Gross‐Goupil,
S.
Varlamov,
E.
Kopyltsov,
J.
Lee,
B.
Melichar,
B.
Rini,
T.
Choueiri,
M.
Zemanova,
L.
Wood,
M.
Reaume,
A.
Stenzl,
S.
Chowdhury,
Ho
Lim,
R.
McDermott,
A.
Michael,
Weichao
Bao,
M.
Carrasco-Alfonso,
P.
Aimone,
M.
Voi,
C.
Doehn,
P.
Russo,
C.
Sternberg
(2017)
Randomized Phase III Trial of Adjuvant Pazopanib Versus Placebo After Nephrectomy in Patients With Localized or Locally Advanced Renal Cell Carcinoma.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology, 35 35
-
R.
Motzer,
B.
Escudier,
P.
Tomczak,
Thomas
Hutson,
M.
Michaelson,
S.
Négrier,
S.
Oudard,
M.
Gore,
J.
Tarazi,
S.
Hariharan,
Connie
Chen,
B.
Rosbrook,
S.
Kim,
B.
Rini
(2013)
Axitinib versus sorafenib as second-line treatment for advanced renal cell carcinoma: overall survival analysis and updated results from a randomised phase 3 trial.
The Lancet. Oncology, 14 6
-
Gregory
Levin,
B.
Kestenbaum,
Y.
Chen,
D.
Jacobs,
B.
Psaty,
J.
Rotter,
D.
Siscovick,
I.
Boer
(2010)
Glucose, insulin, and incident hypertension in the multi-ethnic study of atherosclerosis.
American journal of epidemiology, 172 10
-
G.
Gabb,
A.
Mangoni,
L.
Arnolda
(2017)
Guideline for the diagnosis and management of hypertension in adults — 2016
Medical Journal of Australia, 206
-
Massimo
Cirillo,
M.
Laurenzi,
M.
Trevisan,
J.
Stamler
(1992)
Hematocrit, blood pressure, and hypertension. The Gubbio Population Study.
Hypertension, 20 3
-
S.
Szmit,
P.
Langiewicz,
Jakub
Żłnierek,
Paweł
Nurzyński,
Magdalena
Zaborowska,
K.
Filipiak,
G.
Opolski,
C.
Szczylik
(2011)
Hypertension as a Predictive Factor for Survival Outcomes in Patients with Metastatic Renal Cell Carcinoma Treated with Sunitinib after Progression on Cytokines
Kidney and Blood Pressure Research, 35
-
J.
Kucharz,
P.
Dumnicka,
M.
Kużniewski,
B.
Kuśnierz-Cabala,
R.
Herman,
K.
Krzemieniecki
(2015)
Co-occurring Adverse Events Enable Early Prediction of Progression-free Survival in Metastatic Renal Cell Carcinoma Patients Treated with Sunitinib: A Hypothesis-generating Study
Tumori Journal, 101
-
Clinical practice guidelines for the management of hypertension in the community a statement by the American Society of Hypertension and the International Society of Hypertension
-
F.
Donskov,
M.
Michaelson,
I.
Puzanov,
Mellar
Davis,
G.
Bjarnason,
R.
Motzer,
D.
Goldstein,
Xun
Lin,
D.
Cohen,
R.
Wiltshire,
B.
Rini
(2015)
Sunitinib-associated hypertension and neutropenia as efficacy biomarkers in metastatic renal cell carcinoma patients
British Journal of Cancer, 113
-
H.
Hurwitz,
P.
Douglas,
J.
Middleton,
G.
Sledge,
David
Johnson,
D.
Reardon,
Dafeng
Chen,
O.
Rosen
(2013)
Analysis of early hypertension and clinical outcome with bevacizumab: results from seven phase III studies.
The oncologist, 18 3
-
R.
Iacovelli,
E.
Verri,
M.
Rocca,
G.
Aurilio,
D.
Cullurà,
O.
Cobelli,
F.
Nolè
(2017)
Prognostic role of the cumulative toxicity in patients affected by metastatic renal cells carcinoma and treated with first-line tyrosine kinase inhibitors
Anti-Cancer Drugs, 28
-
Wenxin
Xu,
S.
Goldberg,
M.
Shubina,
A.
Turchin
(2015)
Optimal systolic blood pressure target, time to intensification, and time to follow-up in treatment of hypertension: population based retrospective cohort study
The BMJ, 350
-
B.
Rini,
D.
Cohen,
D.
Lu,
I.
Chen,
S.
Hariharan,
M.
Gore,
R.
Figlin,
M.
Baum,
R.
Motzer
(2011)
Response: Re: Hypertension as a Biomarker of Efficacy in Patients With Metastatic Renal Cell Carcinoma Treated With Sunitinib
Journal of the National Cancer Institute, 103
-
Kiang
Liu,
C.
Ballew,
D.
Jacobs,
S.
Sidney,
P.
Savage,
A.
Dyer,
G.
Hughes,
M.
Blanton
(1989)
Ethnic differences in blood pressure, pulse rate, and related characteristics in young adults. The CARDIA study.
Hypertension, 14 2
-
A.
Johnson,
Tuan
Nguyen,
R.
Day
(1994)
Do Nonsteroidal Anti-inflammatory Drugs Affect Blood Pressure? A Meta-Analysis
Annals of Internal Medicine, 121
-
F.
Petrelli,
G.
Dognini,
M.
Destro,
S.
Barni
(2017)
Hypertension and Survival in Renal Cell Carcinoma Treated with anti-VEGFR Agents: A Systematic Review and Meta-Analysis
Journal of Onco-Nephrology, 1
-
N.
Lawrence,
A.
Martin,
I.
Davis,
S.
Troon,
S.
Sengupta,
E.
Hovey,
X.
Coskinas,
R.
Kaplan,
A.
Ritchie,
A.
Meade,
T.
Eisen,
P.
Blinman,
M.
Stockler
(2017)
881PPredicted benefits of adjuvant sorafenib after nephrectomy for renal cell carcinoma (RCC) in SORCE: an international, placebo-controlled, randomised phase 3 trial
Annals of Oncology, 28
-
H.
Kimura,
H.
Esumi
(2003)
Reciprocal regulation between nitric oxide and vascular endothelial growth factor in angiogenesis.
Acta biochimica Polonica, 50 1
-
D.
Goldstein,
J.
Rosenberg,
R.
Figlin,
R.
Townsend,
L.
McCann,
C.
Carpenter,
L.
Pandite
(2016)
Is change in blood pressure a biomarker of pazopanib and sunitinib efficacy in advanced/metastatic renal cell carcinoma?
European journal of cancer, 53
-
I.
Karpenko,
B.
Singh,
H.
Beltran,
D.
Nanus,
S.
Tagawa
(2013)
Association of CTCAE v4 grading of hypertension with toxicity in patients with renal cancer receiving vascular endothelial growth factor (VEGF)-targeting agents.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology, 31 6_suppl
-
L.
Ellis,
D.
Hicklin
(2008)
VEGF-targeted therapy: mechanisms of anti-tumour activity
Nature Reviews Cancer, 8
-
C.
Escalante,
A.
Zalpour
(2011)
Vascular Endothelial Growth Factor Inhibitor-Induced Hypertension: Basics for Primary Care Providers
Cardiology Research and Practice, 2011
-
P.
Vokonas,
W.
Kannel,
Cupples
La
(1988)
Epidemiology and risk of hypertension in the elderly: the Framingham Study.
Journal of hypertension. Supplement : official journal of the International Society of Hypertension, 6 1
-
Kazuhiko
Nakano,
Kenji
Komatsu,
T.
Kubo,
Shinsuke
Natsui,
A.
Nukui,
S.
Kurokawa,
Minoru
Kobayashi,
T.
Morita
(2013)
Hand-foot skin reaction is associated with the clinical outcome in patients with metastatic renal cell carcinoma treated with sorafenib.
Japanese journal of clinical oncology, 43 10
-
A.
Johnson,
L.
Simons,
J.
Simons,
Y.
Friedlander,
J.
Mccallum
(1993)
Non-steroidal anti-inflammatory drugs and hypertension in the elderly: a community-based cross-sectional study.
British journal of clinical pharmacology, 35 5
-
Sunyoung
Lee,
Tom
Chen,
Chad
Barber,
M.
Jordan,
J.
Murdock,
S.
Desai,
N.
Ferrara,
A.
Nagy,
K.
Roos,
M.
Iruela-Arispe
(2007)
Autocrine VEGF Signaling Is Required for Vascular Homeostasis
Cell, 130
-
A.
Bex,
P.
Nathan,
G.
Oades
(2016)
Cytoreductive nephrectomy in the tyrosine kinase inhibitor era: a question that
-
B.
Rini,
M.
Garrett,
B.
Poland,
J.
Dutcher,
O.
Rixe,
G.
Wilding,
W.
Stadler,
Y.
Pithavala,
S.
Kim,
J.
Tarazi,
R.
Motzer
(2013)
Axitinib in Metastatic Renal Cell Carcinoma: Results of a Pharmacokinetic and Pharmacodynamic Analysis
The Journal of Clinical Pharmacology, 53
-
P.
Bono,
J.
Rautiola,
T.
Utriainen,
H.
Joensuu
(2011)
Hypertension as predictor of sunitinib treatment outcome in metastatic renal cell carcinoma
Acta Oncologica, 50
-
G.
Lombardi,
F.
Zustovich,
P.
Farina,
P.
Fiduccia,
A.
Puppa,
V.
Polo,
R.
Bertorelle,
M.
Gardiman,
A.
Banzato,
P.
Ciccarino,
L.
Denaro,
V.
Zagonel
(2013)
Hypertension as a biomarker in patients with recurrent glioblastoma treated with antiangiogenic drugs: a single-center experience and a critical review of the literature
Anti-Cancer Drugs, 24
-
Jun
Cai,
Hong
Ma,
F.
Huang,
Dichao
Zhu,
J.
Bi,
Yang
Ke,
Tao
Zhang
(2013)
Correlation of bevacizumab-induced hypertension and outcomes of metastatic colorectal cancer patients treated with bevacizumab: a systematic review and meta-analysis
World Journal of Surgical Oncology, 11
-
O.
Hamnvik,
T.
Choueiri,
A.
Turchin,
R.
McKay,
L.
Goyal,
Michael
Davis,
M.
Kaymakcalan,
Jonathan
Williams
(2015)
Clinical risk factors for the development of hypertension in patients treated with inhibitors of the VEGF signaling pathway
Cancer, 121
-
F.
Atsma,
I.
Veldhuizen,
W.
Kort,
M.
Kraaij,
P.
Jong,
J.
Deinum
(2012)
Hemoglobin Level Is Positively Associated With Blood Pressure in a Large Cohort of Healthy Individuals
Hypertension, 60
-
F.
Duffaud,
S.
Sleijfer,
S.
Litière,
I.
Ray-Coquard,
A.
Cesne,
Z.
Pápai,
I.
Judson,
P.
Schöffski,
S.
Chawla,
R.
Dewji,
S.
Marréaud,
J.
Verweij,
W.
Graaf
(2015)
Hypertension (HTN) as a potential biomarker of efficacy in pazopanib-treated patients with advanced non-adipocytic soft tissue sarcoma. A retrospective study based on European Organisation for Research and Treatment of Cancer (EORTC) 62043 and 62072 trials.
European journal of cancer, 51 17
-
Cui
Chen,
P.
Sun,
S.
Ye,
H.
Weng,
Qiang-sheng
Dai
(2014)
Hypertension as a predictive biomarker for efficacy of bevacizumab treatment in metastatic colorectal cancer: a meta-analysis.
Journal of B.U.ON. : official journal of the Balkan Union of Oncology, 19 4
-
M.
Cirillo,
M.
Laurenzi,
M.
Trevisan,
J.
Stamler
(2005)
The Gubbio Population Study
-
A.
Brantsma,
S.
Bakker,
D.
Zeeuw,
P.
Jong,
R.
Gansevoort
(2006)
Urinary albumin excretion as a predictor of the development of hypertension in the general population.
Journal of the American Society of Nephrology : JASN, 17 2
-
(2015)
The impact of diabetes mellitus on renal cell carcinoma prognosis: a meta-analysis of cohort studies
-
M.
Stella,
M.
Failla,
A.
Mangoni,
S.
Carugo,
C.
Giannattasio,
G.
Mancia
(1998)
Effects of isolated systolic hypertension and essential hypertension on large and middle-sized artery compliance.
Blood pressure, 7 2
-
S.
Thanigaimani,
G.
Kichenadasse,
A.
Mangoni
(2011)
The emerging role of vascular endothelial growth factor (VEGF) in vascular homeostasis: lessons from recent trials with anti-VEGF drugs.
Current vascular pharmacology, 9 3
-
Howard
Hu,
David
Sparrow,
Scott
Weiss
(1992)
Association of serum albumin with blood pressure in the normative aging study.
American journal of epidemiology, 136 12
-
N.
Boudville,
G.
Prasad,
G.
Knoll,
N.
Muirhead,
H.
Thiessen-Philbrook,
R.
Yang,
M.
Rosas-Arellano,
A.
Housawi,
A.
Garg
(2006)
Meta-Analysis: Risk for Hypertension in Living Kidney Donors
Annals of Internal Medicine, 145
-
S.
Dahlberg,
A.
Sandler,
J.
Brahmer,
J.
Schiller,
David
Johnson
(2010)
Clinical course of advanced non-small-cell lung cancer patients experiencing hypertension during treatment with bevacizumab in combination with carboplatin and paclitaxel on ECOG 4599.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology, 28 6
-
Kaimin
Hu,
L.
Lou,
Juan
Ye,
Su-zhan
Zhang
(2015)
Prognostic role of the neutrophil–lymphocyte ratio in renal cell carcinoma: a meta-analysis
BMJ Open, 5
-
Xingu
Liu,
Qing
Zhang,
Hongmei
Wu,
H.
Du,
Li
Liu,
Hongbin
Shi,
Chongjin
Wang,
Yang
Xia,
Xiaoyan
Guo,
Chunlei
Li,
X.
Bao,
Q.
Su,
Shaomei
Sun,
Xing
Wang,
Ming
Zhou,
Q.
Jia,
Honglin
Zhao,
K.
Song,
K.
Niu
(2015)
Blood Neutrophil to Lymphocyte Ratio as a Predictor of Hypertension.
American journal of hypertension, 28 11
-
E.
Tahover,
B.
Uziely,
A.
Salah,
M.
Temper,
T.
Peretz,
A.
Hubert
(2013)
Hypertension as a predictive biomarker in bevacizumab treatment for colorectal cancer patients
Medical Oncology, 30
-
Nicola
Fox
(2007)
Cardiovascular system.
Nursing standard (Royal College of Nursing (Great Britain) : 1987), 21 24
-
A.
Wicki,
F.
Hermann,
V.
Pretre,
R.
Winterhalder,
M.
Kueng,
R.
Moos,
C.
Rochlitz,
R.
Herrmann
(2014)
Pre-Existing Antihypertensive Treatment Predicts Early Increase in Blood Pressure during Bevacizumab Therapy: The Prospective AVALUE Cohort Study
Oncology Research and Treatment, 37
-
D.
Keizman,
M.
Gottfried,
M.
Ish‐shalom,
N.
Maimon,
A.
Peer,
A.
Neumann,
H.
Hammers,
M.
Eisenberger,
V.
Sinibaldi,
R.
Pili,
H.
Hayat,
S.
Kovel,
A.
Sella,
B.
Boursi,
R.
Weitzen,
W.
Mermershtain,
K.
Rouvinov,
R.
Berger,
M.
Carducci
(2013)
P034 Active smoking may negatively impact the response rate, progression free survival, and overall survival of patients with metastatic renal cell carcinoma treated with sunitinib
European Urology Supplements, 12
-
J.
Selby,
G.
Friedman,
C.
Quesenberry
(1990)
Precursors of essential hypertension: pulmonary function, heart rate, uric acid, serum cholesterol, and other serum chemistries.
American journal of epidemiology, 131 6
-
D.
Shepard,
L.
Finison
(1983)
Blood pressure reductions: correcting for regression to the mean.
Preventive medicine, 12 2
-
M.
Scartozzi,
E.
Galizia,
S.
Chiorrini,
R.
Giampieri,
R.
Berardi,
C.
Pierantoni,
S.
Cascinu
(2009)
Arterial hypertension correlates with clinical outcome in colorectal cancer patients treated with first-line bevacizumab.
Annals of oncology : official journal of the European Society for Medical Oncology, 20 2
-
S.
Pant,
L.
Martin,
S.
Geyer,
Lai
Wei,
K.
Loon,
Nili
Sommovilla,
M.
Zalupski,
R.
Iyer,
D.
Fogelman,
A.
Ko,
T.
Bekaii-Saab
(2016)
Treatment-related Hypertension as a Pharmacodynamic Biomarker for the Efficacy of Bevacizumab in Advanced Pancreas Cancer: A Pooled Analysis of 4 Prospective Trials of Gemcitabine-based Therapy With Bevacizumab
American Journal of Clinical Oncology, 39
-
M.
Tozawa,
S.
Oshiro,
C.
Iseki,
S.
Sesoko,
Y.
Higashiuesato,
T.
Tana,
Y.
Ikemiya,
K.
Iseki,
K.
Fukiyama
(2001)
Family history of hypertension and blood pressure in a screened cohort.
Hypertension research : official journal of the Japanese Society of Hypertension, 24 2
-
A.
Hoeben,
B.
Landuyt,
M.
Highley,
H.
Wildiers,
A.
Oosterom,
E.
Bruijn
(2004)
Vascular Endothelial Growth Factor and Angiogenesis
Pharmacological Reviews, 56
-
(2013)
Guidelines for the Management of Hypertension in the Community A Statement by the American Society of Hypertension and the International Society of Hypertension
-
A.
Ocaña,
Cristina
Nieto-Jiménez,
A.
Pandiella,
A.
Templeton
(2017)
Neutrophils in cancer: prognostic role and therapeutic strategies
Molecular Cancer, 16
-
Cytoreductive nephrectomy in the tyrosine kinase inhibitor era: a question that may never be answered
-
H.
Izzedine,
L.
Derosa,
G.
Teuff,
L.
Albiges,
B.
Escudier
(2015)
Hypertension and angiotensin system inhibitors: impact on outcome in sunitinib-treated patients for metastatic renal cell carcinoma.
Annals of oncology : official journal of the European Society for Medical Oncology, 26 6